Copyright Reports & Markets. All rights reserved.

Global Paclitaxel-eluting Stent Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Paclitaxel-eluting Stent Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Product
      • 1.4.2 Metal Stent
      • 1.4.3 Polymer Stent
      • 1.4.4 Others
    • 1.5 Market by End User
      • 1.5.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by End User
      • 1.5.2 Coronary Heart Disease
      • 1.5.3 Clinical
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Paclitaxel-eluting Stent Market Size
      • 2.1.1 Global Paclitaxel-eluting Stent Revenue 2014-2025
      • 2.1.2 Global Paclitaxel-eluting Stent Sales 2014-2025
    • 2.2 Paclitaxel-eluting Stent Growth Rate by Regions
      • 2.2.1 Global Paclitaxel-eluting Stent Sales by Regions
      • 2.2.2 Global Paclitaxel-eluting Stent Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Paclitaxel-eluting Stent Sales by Manufacturers
      • 3.1.1 Paclitaxel-eluting Stent Sales by Manufacturers
      • 3.1.2 Paclitaxel-eluting Stent Sales Market Share by Manufacturers
      • 3.1.3 Global Paclitaxel-eluting Stent Market Concentration Ratio (CR5 and HHI)
    • 3.2 Paclitaxel-eluting Stent Revenue by Manufacturers
      • 3.2.1 Paclitaxel-eluting Stent Revenue by Manufacturers (2014-2019)
      • 3.2.2 Paclitaxel-eluting Stent Revenue Share by Manufacturers (2014-2019)
    • 3.3 Paclitaxel-eluting Stent Price by Manufacturers
    • 3.4 Paclitaxel-eluting Stent Manufacturing Base Distribution, Product Types
      • 3.4.1 Paclitaxel-eluting Stent Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Paclitaxel-eluting Stent Product Type
      • 3.4.3 Date of International Manufacturers Enter into Paclitaxel-eluting Stent Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Paclitaxel-eluting Stent Sales by Product
    • 4.2 Global Paclitaxel-eluting Stent Revenue by Product
    • 4.3 Paclitaxel-eluting Stent Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Paclitaxel-eluting Stent Breakdown Data by End User

    6 North America

    • 6.1 North America Paclitaxel-eluting Stent by Countries
      • 6.1.1 North America Paclitaxel-eluting Stent Sales by Countries
      • 6.1.2 North America Paclitaxel-eluting Stent Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Paclitaxel-eluting Stent by Product
    • 6.3 North America Paclitaxel-eluting Stent by End User

    7 Europe

    • 7.1 Europe Paclitaxel-eluting Stent by Countries
      • 7.1.1 Europe Paclitaxel-eluting Stent Sales by Countries
      • 7.1.2 Europe Paclitaxel-eluting Stent Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Paclitaxel-eluting Stent by Product
    • 7.3 Europe Paclitaxel-eluting Stent by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Paclitaxel-eluting Stent by Countries
      • 8.1.1 Asia Pacific Paclitaxel-eluting Stent Sales by Countries
      • 8.1.2 Asia Pacific Paclitaxel-eluting Stent Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Paclitaxel-eluting Stent by Product
    • 8.3 Asia Pacific Paclitaxel-eluting Stent by End User

    9 Central & South America

    • 9.1 Central & South America Paclitaxel-eluting Stent by Countries
      • 9.1.1 Central & South America Paclitaxel-eluting Stent Sales by Countries
      • 9.1.2 Central & South America Paclitaxel-eluting Stent Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Paclitaxel-eluting Stent by Product
    • 9.3 Central & South America Paclitaxel-eluting Stent by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Paclitaxel-eluting Stent by Countries
      • 10.1.1 Middle East and Africa Paclitaxel-eluting Stent Sales by Countries
      • 10.1.2 Middle East and Africa Paclitaxel-eluting Stent Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Paclitaxel-eluting Stent by Product
    • 10.3 Middle East and Africa Paclitaxel-eluting Stent by End User

    11 Company Profiles

    • 11.1 B.Braun Melsengen AG
      • 11.1.1 B.Braun Melsengen AG Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 B.Braun Melsengen AG Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 B.Braun Melsengen AG Paclitaxel-eluting Stent Products Offered
      • 11.1.5 B.Braun Melsengen AG Recent Development
    • 11.2 Biosensors
      • 11.2.1 Biosensors Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Biosensors Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Biosensors Paclitaxel-eluting Stent Products Offered
      • 11.2.5 Biosensors Recent Development
    • 11.3 Biotronik
      • 11.3.1 Biotronik Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Biotronik Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Biotronik Paclitaxel-eluting Stent Products Offered
      • 11.3.5 Biotronik Recent Development
    • 11.4 Blue Medical
      • 11.4.1 Blue Medical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Blue Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Blue Medical Paclitaxel-eluting Stent Products Offered
      • 11.4.5 Blue Medical Recent Development
    • 11.5 Boston Scientific
      • 11.5.1 Boston Scientific Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Boston Scientific Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Boston Scientific Paclitaxel-eluting Stent Products Offered
      • 11.5.5 Boston Scientific Recent Development
    • 11.6 DISA Vascular
      • 11.6.1 DISA Vascular Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 DISA Vascular Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 DISA Vascular Paclitaxel-eluting Stent Products Offered
      • 11.6.5 DISA Vascular Recent Development
    • 11.7 Essen
      • 11.7.1 Essen Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Essen Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Essen Paclitaxel-eluting Stent Products Offered
      • 11.7.5 Essen Recent Development
    • 11.8 Medtronic Vascular
      • 11.8.1 Medtronic Vascular Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Medtronic Vascular Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Medtronic Vascular Paclitaxel-eluting Stent Products Offered
      • 11.8.5 Medtronic Vascular Recent Development
    • 11.9 MicroPort Medical
      • 11.9.1 MicroPort Medical Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 MicroPort Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 MicroPort Medical Paclitaxel-eluting Stent Products Offered
      • 11.9.5 MicroPort Medical Recent Development
    • 11.10 Terumo Medical
      • 11.10.1 Terumo Medical Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Terumo Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Terumo Medical Paclitaxel-eluting Stent Products Offered
      • 11.10.5 Terumo Medical Recent Development
    • 11.11 Orbusneich

    12 Future Forecast

    • 12.1 Paclitaxel-eluting Stent Market Forecast by Regions
      • 12.1.1 Global Paclitaxel-eluting Stent Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Paclitaxel-eluting Stent Revenue Forecast by Regions 2019-2025
    • 12.2 Paclitaxel-eluting Stent Market Forecast by Product
      • 12.2.1 Global Paclitaxel-eluting Stent Sales Forecast by Product 2019-2025
      • 12.2.2 Global Paclitaxel-eluting Stent Revenue Forecast by Product 2019-2025
    • 12.3 Paclitaxel-eluting Stent Market Forecast by End User
    • 12.4 North America Paclitaxel-eluting Stent Forecast
    • 12.5 Europe Paclitaxel-eluting Stent Forecast
    • 12.6 Asia Pacific Paclitaxel-eluting Stent Forecast
    • 12.7 Central & South America Paclitaxel-eluting Stent Forecast
    • 12.8 Middle East and Africa Paclitaxel-eluting Stent Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Paclitaxel-eluting Stent Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Paclitaxel-eluting stent is used to prevent cell proliferation and avoid fibrosis that could block the stented artery with the clots in a process called restenosis. The stents are scaffolds that can be placed inside diseased or narrowed coronary arteries to release a drug (at a slow speed) to inhibit cell proliferation.
      The global Paclitaxel-eluting Stent market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Paclitaxel-eluting Stent market based on company, product type, end user and key regions.

      This report studies the global market size of Paclitaxel-eluting Stent in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Paclitaxel-eluting Stent in these regions.
      This research report categorizes the global Paclitaxel-eluting Stent market by top players/brands, region, type and end user. This report also studies the global Paclitaxel-eluting Stent market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      B.Braun Melsengen AG
      Biosensors
      Biotronik
      Blue Medical
      Boston Scientific
      DISA Vascular
      Essen
      Medtronic Vascular
      MicroPort Medical
      Terumo Medical
      Orbusneich

      Market size by Product
      Metal Stent
      Polymer Stent
      Others
      Market size by End User
      Coronary Heart Disease
      Clinical
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Paclitaxel-eluting Stent market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Paclitaxel-eluting Stent market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Paclitaxel-eluting Stent companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Paclitaxel-eluting Stent submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Paclitaxel-eluting Stent are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Paclitaxel-eluting Stent market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now